West Palm Beach, Florida headquartered Rennova Health Inc.'s stock finished Friday's session 1.35% lower at $0.15 with a total volume of 229,943 shares traded. Shares of Rennova Health, which provides diagnostics and supportive software solutions to healthcare providers, traded at a PE ratio of 0.31. The Company's shares are trading below its 50-day and 200-day moving averages by 38.70% and 75.06%, respectively. Rennova Health's stock has a Relative Strength Index (RSI) of 18.80. Visit us today and download your complete report on RNVA for free at:
North Kansas City, Missouri headquartered Cerner Corp.'s stock edged 0.44% higher, to close the day at $61.13. The stock recorded a trading volume of 1.13 million shares. Shares of Cerner, which designs, develops, markets, installs, hosts, and supports health care information technology, health care devices, hardware, and content solutions for health care organizations and consumers in the US and internationally, have advanced 1.71% in the past three months. The Company's shares are trading 5.43% above its 200-day moving average. Additionally, the stock traded at a PE ratio of 33.68 and has an RSI of 36.54.
On September 19th, 2016, research firm Bank of America/Merrill initiated a 'Neutral' rating on the Company's stock, issuing a target price of $67 per share. The complimentary research report on CERN can be accessed at:
On Friday, shares in Pleasanton, California headquartered Veeva Systems Inc. ended the session 0.41% lower at $38.84 with a total volume of 1.54 million shares traded. Veeva Systems' shares have gained 5.20% in the last three months and 54.00% in the previous one year. The stock is trading 24.49% above its 200-day moving average. Shares of the Company, which provides industry cloud software and data solutions for the life sciences industry in North America, the European Union, the Asia Pacific, and internationally, traded at a PE ratio of 100.36. Moreover, the Company's shares have an RSI of 37.79.
On October 4th, 2016, research firm Goldman initiated a 'Neutral' rating on the Company's stock. Register for free on Stock-Callers.com and download the PDF research report on VEEV at:
On Friday, shares in Bowie, Maryland headquartered Inovalon Holdings Inc. recorded a trading volume of 432,801 shares. The stock ended the day 0.84% higher at $14.49. Shares of the Company, which provides cloud-based data analytics and data-driven intervention platforms in the US, traded at a PE ratio of 49.45. The Company is trading below its 50-day and 200-day moving averages by 7.42% and 16.35%, respectively. Furthermore, shares of Inovalon Holdings have an RSI of 37.94. Get free access to your research report on INOV at:
Stock Callers (SC) produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. SC has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.
SC has not been compensated; directly or indirectly; for producing or publishing this document.
PRESS RELEASE PROCEDURES:
The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer") represented by a credentialed financial analyst [for further information on analyst credentials, please email email@example.com. Rohit Tuli, a CFA® charterholder (the "Sponsor"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on publicly available information which is believed to be reliable. Content is researched, written and reviewed on a reasonable-effort basis. The Reviewer has not performed any independent investigations or forensic audits to validate the information herein. The Reviewer has only independently reviewed the information provided by the Author according to the procedures outlined by SC. SC is not entitled to veto or interfere in the application of such procedures by the third-party research service company to the articles, documents or reports, as the case may be. Unless otherwise noted, any content outside of this document has no association with the Author or the Reviewer in any way.
SC, the Author, and the Reviewer are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted whatsoever for any direct, indirect or consequential loss arising from the use of this document. SC, the Author, and the Reviewer expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, SC, the Author, and the Reviewer do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.
NOT AN OFFERING
This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither SC nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit
For any questions, inquiries, or comments reach out to us directly. If you're a company we are covering and wish to no longer feature on our coverage list contact us via email and/or phone between 09:30 EDT to 16:00 EDT from Monday to Friday at:
Phone number: +44 330 808 3765
Office Address: Clyde Offices, Second Floor, 48 West George Street, Glasgow, U.K. -G2 1BP
CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.
SOURCE Chelmsford Park SA